Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Lisa PierceyIndependent Director | 949,00 | 174,86k | Kauf | 184,26 | 949,00 | - |
| 2026-05-21 | Mr. Richard F. LaRocheIndependent Director | -7,50k | 1,46M | Verkauf | 195,14 | 359,88k | -2,04% |
| 2026-05-20 | Dr. Stephen Fowler FlattCEO, President & Director | -26,00 | 0,00 | Other Disposition | - | 66,99k | -0,04% |
| 2026-05-19 | Mr. Timothy J. ShellyInsider | -1,85k | 365,44k | Verkauf | 197,22 | 1,29k | -58,88% |
| 2026-05-14 | Dr. Stephen Fowler FlattCEO, President & Director | -4,49k | 470,02k | Derivative Exercise and Sale | 90,62 - 197,96 | 67,01k | - |
| 2026-05-14 | Dr. Stephen Fowler FlattCEO, President & Director | 1,51k | 141,90k | Derivative Exercise and Retained Stock | 94,10 | 67,01k | 2,30% |
| 2026-05-14 | Mr. Brian Frederick KiddSenior VP & CFO | 1,37k | 128,54k | Derivative Exercise and Retained Stock | 94,10 | 30,50k | 4,69% |
| 2026-05-14 | Mr. Brian Frederick KiddSenior VP & CFO | -3,13k | 327,24k | Derivative Exercise and Sale | 90,62 - 197,96 | 30,50k | - |
| 2026-05-06 | Ms. Sandra Y. TrailIndependent Director | 3,14k | 175,06k | Derivative Exercise and Retained Stock | 55,75 | 10,64k | 41,87% |
| 2026-05-05 | Mr. Richard F. LaRocheIndependent Director | 7,50k | 537,30k | Derivative Exercise and Retained Stock | 71,64 | 367,38k | 2,08% |
| 2026-04-30 | Mr. Emil E. HassanIndependent Director | 7,50k | 537,30k | Derivative Exercise and Retained Stock | 71,64 | 73,10k | 11,43% |
| 2026-04-22 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 1,15k | 107,93k | Derivative Exercise and Retained Stock | 94,10 | 15,56k | 7,96% |
| 2026-04-22 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -2,85k | 226,90k | Derivative Exercise and Sale | 94,10 - 173,63 | 15,56k | - |
| 2026-04-09 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -2,11k | 372,89k | Sale to Issuer | 176,81 | 21,18k | -9,06% |
| 2026-04-09 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | 3,73k | 201,41k | Derivative Exercise and Retained Stock | 53,94 | 21,18k | 21,41% |
| 2026-03-16 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 1,70k | 91,70k | Derivative Exercise and Retained Stock | 53,94 | 14,41k | 13,37% |
| 2026-03-16 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -2,03k | 225,81k | Derivative Exercise and Sale | 53,94 - 164,96 | 14,41k | - |
| 2026-03-12 | Dr. Stephen Fowler FlattCEO, President & Director | 1,85k | 99,95k | Derivative Exercise and Retained Stock | 53,94 | 65,51k | 2,91% |
| 2026-03-12 | Mr. Brian Frederick KiddSenior VP & CFO | 1,85k | 99,95k | Derivative Exercise and Retained Stock | 53,94 | 29,13k | 6,79% |
| 2026-03-09 | Dr. James Paul AbernathyIndependent Director | 3,14k | 175,06k | Derivative Exercise and Retained Stock | 55,75 | 43,30k | 7,82% |
| 2026-03-04 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 1,34k | 121,52k | Derivative Exercise and Retained Stock | 90,62 | 12,71k | 11,79% |
| 2026-03-04 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -3,16k | 259,70k | Derivative Exercise and Sale | 90,62 - 172,83 | 12,71k | - |
| 2026-03-04 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | 4,09k | 235,05k | Derivative Exercise and Retained Stock | 53,94 - 94,10 | 19,55k | 26,46% |
| 2026-03-04 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -8,14k | 656,68k | Derivative Exercise and Sale | 90,62 - 172,83 | 19,55k | - |
| 2026-03-04 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 1,30k | 117,62k | Derivative Exercise and Retained Stock | 90,62 | 12,70k | 11,39% |
| 2026-03-04 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -3,20k | 263,24k | Derivative Exercise and Sale | 90,62 - 172,83 | 12,70k | - |
| 2026-03-04 | Mr. Timothy J. ShellyInsider | 1,85k | 174,37k | Derivative Exercise and Retained Stock | 94,10 | 3,15k | 143,20% |
| 2026-03-04 | Mr. Timothy J. ShellyInsider | -4,48k | 365,55k | Derivative Exercise and Sale | 90,62 - 172,83 | 3,15k | - |
| 2026-03-04 | Mr. Brian Frederick KiddSenior VP & CFO | 2,05k | 112,68k | Derivative Exercise and Retained Stock | 53,94 - 90,62 | 27,28k | 8,14% |
| 2026-03-04 | Mr. Brian Frederick KiddSenior VP & CFO | -3,95k | 324,48k | Derivative Exercise and Sale | 90,62 - 172,83 | 27,28k | - |
| 2026-03-02 | Dr. Stephen Fowler FlattCEO, President & Director | 1,42k | 128,23k | Derivative Exercise and Retained Stock | 90,62 | 63,65k | 2,27% |
| 2026-03-02 | Dr. Stephen Fowler FlattCEO, President & Director | -3,59k | 288,70k | Derivative Exercise and Sale | 90,62 - 171,15 | 63,65k | - |
| 2026-01-15 | Dr. James Paul AbernathyIndependent Director | 3,77k | 263,08k | Derivative Exercise and Retained Stock | 69,82 | 40,16k | 10,35% |
| 2026-01-15 | Dr. James Paul AbernathyIndependent Director | -3,73k | 258,22k | Derivative Exercise and Sale | 69,82 - 139,01 | 40,16k | - |
| 2025-11-11 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -496,00 | 68,40k | Sale to Issuer | 137,90 | 9,94k | -4,75% |
| 2025-12-31 | Mr. R. Michael UsseryInsider | -2,06k | 282,82k | Sale to Issuer | 137,09 | 158,46k | -1,29% |
| 2026-01-01 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -403,00 | 55,25k | Sale to Issuer | 137,09 | 14,12k | -2,78% |
| 2026-01-01 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -319,00 | 43,73k | Sale to Issuer | 137,09 | 10,29k | -3,01% |
| 2026-01-01 | Mr. Brian Frederick KiddSenior VP & CFO | -447,00 | 61,28k | Sale to Issuer | 137,09 | 23,69k | -1,85% |
| 2025-01-01 | Dr. Stephen Fowler FlattCEO, President & Director | -1,02k | 140,38k | Sale to Issuer | 137,09 | 59,15k | -1,70% |
| 2025-12-29 | Dr. Stephen Fowler FlattCEO, President & Director | -450,00 | 0,00 | Other Disposition | - | 60,17k | -0,74% |
| 2025-12-23 | Mr. Brian Frederick KiddSenior VP & CFO | -350,00 | 0,00 | Other Disposition | - | 24,14k | -1,43% |
| 2025-12-17 | Mr. Timothy J. ShellyInsider | -2,45k | 342,14k | Verkauf | 139,42 | 0,00 | -100,00% |
| 2025-12-17 | Mr. R. Michael UsseryInsider | -1.000,00 | 0,00 | Other Disposition | - | 160,52k | -0,62% |
| 2025-12-12 | Dr. Stephen Fowler FlattCEO, President & Director | -362,00 | 0,00 | Other Disposition | - | 60,62k | -0,59% |
| 2025-12-01 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | 1,35k | 86,28k | Derivative Exercise and Retained Stock | 63,96 | 14,52k | 10,24% |
| 2025-12-01 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -2,39k | 174,89k | Derivative Exercise and Sale | 63,96 - 137,29 | 14,52k | - |
| 2025-11-25 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 860,00 | 80,93k | Derivative Exercise and Retained Stock | 94,10 | 10,61k | 8,82% |
| 2025-11-25 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -3,14k | 137,69k | Derivative Exercise and Sale | 94,10 - 137,95 | 10,61k | - |
| 2025-11-25 | Mr. Emil E. HassanIndependent Director | -7,50k | 1,04M | Verkauf | 138,52 | 65,60k | -10,26% |
| 2025-11-25 | Dr. Stephen Fowler FlattCEO, President & Director | 1,85k | 99,95k | Derivative Exercise and Retained Stock | 53,94 | 60,98k | 3,13% |
| 2025-11-21 | Dr. Stephen Fowler FlattCEO, President & Director | -1.000,00 | 130,33k | Verkauf | 130,33 | 60,98k | -1,61% |
| 2025-11-11 | Mr. R. Michael UsseryInsider | 3,58k | 224,16k | Derivative Exercise and Retained Stock | 53,94 - 94,10 | 161,52k | 2,26% |
| 2025-11-11 | Mr. R. Michael UsseryInsider | -5,43k | 275,17k | Derivative Exercise and Sale | 53,94 - 132,20 | 161,52k | - |
| 2025-11-11 | Mr. Timothy J. ShellyInsider | 2,45k | 139,83k | Derivative Exercise and Retained Stock | 53,94 - 63,96 | 2,45k | - |
| 2025-11-11 | Mr. Timothy J. ShellyInsider | -4,75k | 354,84k | Derivative Exercise and Sale | 53,94 - 132,20 | 2,45k | - |
| 2025-11-11 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 722,00 | 67,94k | Derivative Exercise and Retained Stock | 94,10 | 10,44k | 7,43% |
| 2025-11-11 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -3,28k | 124,89k | Derivative Exercise and Sale | 94,10 - 132,20 | 10,44k | - |
| 2025-11-11 | Mr. Brian Frederick KiddSenior VP & CFO | 776,00 | 73,02k | Derivative Exercise and Retained Stock | 94,10 | 24,49k | 3,27% |
| 2025-11-11 | Mr. Brian Frederick KiddSenior VP & CFO | -3,22k | 122,83k | Derivative Exercise and Sale | 94,10 - 132,20 | 24,49k | - |
| 2025-11-11 | Dr. Stephen Fowler FlattCEO, President & Director | 520,00 | 48,93k | Derivative Exercise and Retained Stock | 94,10 | 60,13k | 0,87% |
| 2025-11-11 | Dr. Stephen Fowler FlattCEO, President & Director | -2,48k | 94,49k | Derivative Exercise and Sale | 94,10 - 132,20 | 60,13k | - |
| 2025-11-12 | Mr. Emil E. HassanIndependent Director | -5,50k | 731,50k | Verkauf | 133,00 | 73,10k | -7,00% |
| 2025-09-19 | Mr. Robert Galloway AdamsIndependent Chairman | 4,50k | 322,38k | Derivative Exercise and Retained Stock | 71,64 | 443,92k | 1,02% |
| 2025-08-22 | Dr. Stephen Fowler FlattCEO, President & Director | 854,00 | 54,78k | Derivative Exercise and Retained Stock | 53,94 - 94,10 | 59,61k | 1,45% |
| 2025-08-22 | Dr. Stephen Fowler FlattCEO, President & Director | -3,15k | 119,92k | Derivative Exercise and Sale | 53,94 - 114,82 | 59,61k | - |
| 2025-08-13 | Dr. James Paul AbernathyIndependent Director | 1,37k | 98,22k | Derivative Exercise and Retained Stock | 71,64 | 36,39k | 3,91% |
| 2025-08-13 | Dr. James Paul AbernathyIndependent Director | -2,64k | 98,12k | Derivative Exercise and Sale | 71,64 - 108,82 | 36,39k | - |
| 2025-08-13 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 1,26k | 68,13k | Derivative Exercise and Retained Stock | 53,94 | 9,72k | 14,94% |
| 2025-08-13 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -2,74k | 150,21k | Derivative Exercise and Sale | 53,94 - 108,82 | 9,72k | - |
| 2025-06-26 | Mr. R. Michael UsseryInsider | 2,23k | 142,44k | Derivative Exercise and Retained Stock | 63,96 | 157,95k | 1,43% |
| 2025-06-26 | Mr. R. Michael UsseryInsider | -2,01k | 90,50k | Derivative Exercise and Sale | 63,96 - 109,05 | 157,95k | - |
| 2025-06-26 | Dr. Stephen Fowler FlattCEO, President & Director | 1,18k | 75,28k | Derivative Exercise and Retained Stock | 63,96 | 58,76k | 2,04% |
| 2025-06-26 | Dr. Stephen Fowler FlattCEO, President & Director | -3,56k | 160,39k | Derivative Exercise and Sale | 63,96 - 109,05 | 58,76k | - |
| 2025-06-26 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -788,00 | 0,00 | Other Disposition | - | 8,96k | -8,08% |
| 2025-06-12 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 2,20k | 128,60k | Derivative Exercise and Retained Stock | 53,94 - 63,96 | 9,75k | 29,18% |
| 2025-06-12 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -5,27k | 238,92k | Derivative Exercise and Sale | 53,94 - 104,56 | 9,75k | - |
| 2025-06-06 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 929,00 | 59,42k | Derivative Exercise and Retained Stock | 63,96 | 8,45k | 12,35% |
| 2025-06-06 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -2,81k | 118,20k | Derivative Exercise and Sale | 63,96 - 106,10 | 8,45k | - |
| 2025-06-03 | Mr. Richard F. LaRocheIndependent Director | -152,00 | 15,91k | Other Disposition | 104,69 | 359,88k | -0,04% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
